Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Beauty Health (SKIN) Receivables (2020 - 2025)

Beauty Health (SKIN) has disclosed Receivables for 6 consecutive years, with $21.7 million as the latest value for Q4 2025.

  • Quarterly Receivables fell 24.1% to $21.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $21.7 million through Dec 2025, down 24.1% year-over-year, with the annual reading at $21.7 million for FY2025, 24.1% down from the prior year.
  • Receivables for Q4 2025 was $21.7 million at Beauty Health, down from $22.2 million in the prior quarter.
  • The five-year high for Receivables was $84.0 million in Q3 2022, with the low at $21.7 million in Q4 2025.
  • Average Receivables over 5 years is $51.9 million, with a median of $50.4 million recorded in 2024.
  • The sharpest move saw Receivables skyrocketed 150.81% in 2021, then crashed 61.02% in 2025.
  • Over 5 years, Receivables stood at $47.2 million in 2021, then surged by 74.71% to $82.5 million in 2022, then fell by 15.51% to $69.7 million in 2023, then crashed by 58.9% to $28.6 million in 2024, then decreased by 24.1% to $21.7 million in 2025.
  • According to Business Quant data, Receivables over the past three periods came in at $21.7 million, $22.2 million, and $25.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.